Month: June 2026

As oral drug delivery moves beyond the small intestine, ileocolonic targeting is emerging as a key enabler for next‑generation therapeutics. This article explores how colonic delivery technologies – including pH‑dependent polymers, multi‑trigger coatings and ready‑to‑fill […]

Researchers at the Icahn School of Medicine at Mount Sinai have developed a new manufacturing platform for producing targeted mixtures of beneficial gut bacteria, an approach that could help expand access to microbiome-based therapies for […]

The global probiotics market has experienced sustained and rapid growth over the past decade, driven by increasing consumer awareness of gut health, immunity, and the central role of the microbiome in overall well‑being. Discussions at […]